EPS8
EPS8[edit | edit source]
The structure of EPS8 protein.
EPS8 (Epidermal Growth Factor Receptor Pathway Substrate 8) is a protein that plays a crucial role in various cellular processes, including cell growth, migration, and signaling. It is encoded by the EPS8 gene, which is located on chromosome 12 in humans. EPS8 is primarily known for its involvement in the epidermal growth factor receptor (EGFR) signaling pathway, but it also interacts with other signaling molecules and proteins.
Structure[edit | edit source]
The EPS8 protein consists of several functional domains that contribute to its diverse functions. It contains an N-terminal phosphotyrosine-binding (PTB) domain, which allows it to interact with phosphorylated proteins. This domain is followed by a Src homology 3 (SH3) domain, which mediates protein-protein interactions. The C-terminal region of EPS8 contains a conserved region known as the EPS8 homology (EH) domain, which is involved in protein-protein interactions and membrane binding.
Function[edit | edit source]
EPS8 is involved in the regulation of cell growth and migration through its interactions with various signaling molecules. It acts as an adaptor protein, linking activated EGFR to downstream signaling pathways. EPS8 binds to the activated EGFR through its PTB domain and recruits other proteins, such as SOS1 and Grb2, to form a signaling complex. This complex activates the Ras-MAPK pathway, leading to cell proliferation and survival.
In addition to its role in EGFR signaling, EPS8 also interacts with other proteins and contributes to various cellular processes. It has been shown to regulate actin cytoskeleton dynamics by binding to actin filaments and promoting actin polymerization. EPS8 also interacts with other actin-binding proteins, such as Abi1 and Sos1, to regulate actin remodeling and cell migration.
Clinical Significance[edit | edit source]
Abnormal expression or dysregulation of EPS8 has been implicated in several diseases, including cancer. Overexpression of EPS8 has been observed in various types of cancer, such as breast, lung, and colorectal cancer. High levels of EPS8 have been associated with increased tumor growth, invasion, and metastasis. Therefore, EPS8 has emerged as a potential therapeutic target for cancer treatment.
References[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD